Metraipolis › archive › dc_b267e75247f2

Biological Evaluation of a Novel Compound with Predicted EZH2 and EED Binding Against Human Malignant Melanoma Cells — Europe PMC PMID:41898517

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41898517
DOI
10.3390/ijms27062647
License (as archived)
solo-consultazione
Archived
2026-11-04T19:35:15.106Z
SHA-256 of the archived text
0156dcca6ecd866a91d6ae9d48bf80846f3656b992977c11d331916aecfa86d0
Stable URL of this page
https://metraipolis.com/documento/dc_b267e75247f2

How to cite

Biological Evaluation of a Novel Compound with Predicted EZH2 and EED Binding Against Human Malignant Melanoma Cells — Europe PMC PMID:41898517 — Europe PMC (en), https://europepmc.org/article/MED/41898517 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b267e75247f2 (Metraipolis archive dc_b267e75247f2, sha256 0156dcca6ecd866a91d6ae9d48bf80846f3656b992977c11d331916aecfa86d0)
BibTeX
@misc{dcb267e75247f2,
  title = {Biological Evaluation of a Novel Compound with Predicted EZH2 and EED Binding Against Human Malignant Melanoma Cells — Europe PMC PMID:41898517},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41898517},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b267e75247f2; sha256 0156dcca6ecd866a91d6ae9d48bf80846f3656b992977c11d331916aecfa86d0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41898517. Agents can read the archived copy with the MCP tool read_document.